Juvobin 25 Injection
Prescription Required
Product introduction
Juvobin 25 Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy. It works by stimulating the bone marrow to produce more red blood cells.
Juvobin 25 Injection is used to treat anemia (deficiency of red blood cells in blood)
Juvobin 25 Injection is used to treat anemia (deficiency of red blood cells in blood)
Uses of Juvobin Injection
Benefits of Juvobin Injection
In Treatment of Anemia due to chronic kidney disease
Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. Chronic kidney disease (CKD) refers to the loss of normal kidney function over a long span of time. CKD progresses gradually over a few years but may become permanent if left untreated. CKD can lead to anemia. Juvobin 25 Injection can boost your levels of red blood cells and reduce the symptoms of anemia such as tiredness and weakness. Taking this injection improves the quality of life.
In Treatment of Anemia due to cancer chemotherapy
Low red blood cell count is termed as anemia. Cancer treatment with chemotherapy often causes many side effects, one of the major ones being anemia. Juvobin 25 Injection stimulates the production of red blood cells in bone marrow and regulates the haemoglobin in the blood. This treats anemia in cancer patients receiving chemotherapy.
Side effects of Juvobin Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Juvobin
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Juvobin Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Juvobin 25 Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Juvobin 25 Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Juvobin 25 Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Juvobin 25 Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Juvobin 25 Injection is safe to use in patients with kidney disease. No dose adjustment of Juvobin 25 Injection is recommended.
Liver
CAUTION
Juvobin 25 Injection should be used with caution in patients with liver disease. Dose adjustment of Juvobin 25 Injection may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Juvobin 25 Injection
₹1599.0/Injection
Dargen 25 Injection
Lupin Ltd
₹1523/injection
5% cheaper
Actorise 25 Injection
Cipla Ltd
₹1650/injection
3% costlier
Cresp 25 Injection
Dr Reddy's Laboratories Ltd
₹1749/injection
9% costlier
Darcept 25 Injection
LG Lifesciences
₹1800/injection
13% costlier
Darbatitor 25mcg Injection
Torrent Pharmaceuticals Ltd
₹1585/injection
1% cheaper
Quick tips
- Juvobin 25 Injection helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy.
- It is given as a single injection under your skin, additionally, it can be given intravenously.
- Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells, in your blood.
- Stop taking Juvobin 25 Injection and inform your doctor if you develop shortness of breath or skin rash.
Fact Box
Chemical Class
Amino Acids, Peptides Analogues
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Erythropoiesis-stimulating agent (ESA)
Patient concerns
User feedback
Patients taking Juvobin 25 Injection
Once A Week
49%
Twice A Month
20%
Once A Month
20%
Once A Day
8%
Twice A Week
2%
FAQs
How long does it take for Juvobin 25 Injection to start working?
You will be able to notice an increase in the count of red blood cells (hemoglobin levels) in 2-6 weeks of starting Juvobin 25 Injection. If you have any other concerns, consult your doctor.
Is Juvobin 25 Injection safe to use?
Juvobin 25 Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects and even death of the patient. It is important that you seek treatment from a doctor who is experienced in providing Juvobin 25 Injection therapy. Follow all the directions strictly.
Other than PRCA, can there be other reasons for not responding to Juvobin 25 Injection?
You may not respond to Juvobin 25 Injection if you have deficiencies of iron, folic acid or vitamin B12. It is important that you take measures to correct these deficiencies. Other reasons behind not responding to the treatment could be bleeding, infections, inflammation and bone marrow fibrosis. Therefore, consult our doctor regarding the same.
Can Juvobin 25 Injection be used in children?
Yes, Juvobin 25 Injection is used to treat anemia due to chronic kidney disease in children who are above 1 year of age. The effectiveness of Juvobin 25 Injection and side effects seen in children are similar to adults. However, consult your doctor if you are not sure.
Can Juvobin 25 Injection affect blood pressure?
Yes, Juvobin 25 Injection can affect blood pressure. During initial therapy with Juvobin 25 Injection, blood pressure should be monitored and those who have high blood pressure should take appropriate measures to control blood pressure. Your doctor may stop Juvobin 25 Injection if the blood pressure remains uncontrolled.
Who should not take Juvobin 25 Injection?
Individuals who have cancer but have not been prescribed Juvobin 25 Injection by the doctor should not take it. Additionally, patients with uncontrolled hypertension (high blood pressure), patients with a history of anemia called pure red cell aplasia (PRCA) that starts after treatment with Juvobin 25 Injection or other erythropoietin medicines, and patients with a history of serious allergic reaction to this medicine should not take this medicine.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Kaushansky K, Kipps TJ. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1071-72.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 358-59.
- Darbepoetin alfa. Milton Road, Cambridge: Amgen Ltd.; 2001 [revised Sep. 2017]. [Accessed 23 Jan. 2019] (online) Available from:
- Darbepoetin alfa. Thousand Oaks, CA: Amgen Inc.; 2001. [Accessed 07 Apr. 2019] (online) Available from:
- CiplaMed. Darbepoetin Alfa [Product Information]. [Last Reviewed: June 2019]. [Accessed 17 Jun. 2023] (online) Available from:
- Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006. Darbepoetin. [Accessed 17 Jun. 2023] (online) Available from:
- Darbepoetin alfa [Prescribing Information]. Thousand Oaks, California: Amgen Inc.; 2019. [Accessed 17 Jun. 2023] (online) Available from:
- Aranesp Injection (Darbepoetin alfa) [Product Information]. [Accessed 17 Jun. 2023] (online) Available from:
Marketer details
Name: La Renon Healthcare Pvt Ltd
Address: Behind Rajpath Club, Kensville Road, Opp. Infostretch Building, Off S.G. Highway, Ahmedabad- 380059, Gujarat- India
Country of origin: India
Lab tests offered by us
Related/Popular tests
158 people viewed this recentlyMRP
₹1599
Inclusive of all taxes
0.42 ml in 1 prefilled syringe
SOLD OUT